Advertisement

Factors Modifying Toxicity

  • Gary P. Carlson
Part of the Life Science Monographs book series (LSMO)

Abstract

In the evaluation of hazards associated with exposure of humans to chemicals, whether they be encountered as drugs, through occupational exposure, or as the result of environmental contamination, the use of animal data is of obvious importance. In the usual safety evaluation studies of a compound in laboratory animals, environmental conditions are controlled as carefully as possible, animal bedding and food are selected with great diligence, and the utmost care is taken to maintain the health of the animals in order to minimize confounding variables. In order to institute the proper controls, one must first recognize the factors that affect the responses of animals to exposures to toxic chemicals. Some of these are discussed in this chapter.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acheson, E. D., R. H. Cowdell, E. Hadfield, and R. G. Macbeth. 1968. Nasal cancer in woodworkers in the furniture industry.Br. Med. J. 2:587–596.Google Scholar
  2. Ackerman, D. M., and K. C. Leibman. 1977. Effect of experimental diabetes on drug metabolism in the rat.Drug Metab. Dispos. 5:405–410.Google Scholar
  3. Adamson, R. H., J. W. Bridges, M. E. Evans, and R. T. Williams. 1970. Species differences in the aromatization of quinic acidin vivoand the role of gut bacteria.Biochem. J. 116:437–443.Google Scholar
  4. Alam, S. N., R. J. Roberts, and L. J. Fisher. 1977. Age-related differences in salicylamide and acetaminophen conjugation in man.J. Pediatr. 90:130–135.Google Scholar
  5. Alary, J. G., and J. Brodeur. 1970. Correlation between the activity of liver enzymes and the LD50 of parathion in the rat.Can. J. Physiol. Pharmacol. 48:829–831.Google Scholar
  6. Ambre, J., F. Butes, D. Haupt, D. Graeff, and K. Deason. 1974. Antipyrine metabolism in patients with lung cancer.Clin. Res. 22:598A.Google Scholar
  7. Andersen, H. C., I. Andersen, and J. Solgaard. 1977. Nasal cancers, symptoms and upper airway function in woodworkers.Br. J. Ind. Med. 34:201–207.Google Scholar
  8. Anonymous. 1980. Caffeine and pregnancy.FDA Drug Bull. 10:19–20.Google Scholar
  9. Aranda, J. V., S. M. MacLeod, K. W. Renton, and N. R. Eade. 1974. Hepatic microsomal drug oxidation and electron transport in newborn infants.Pediatr. Pharmacol. Ther. 85:534–542.Google Scholar
  10. Axelrod, J., S. Udenfriend, and B. B. Brodie. 1954. Ascorbic acid in aromatic hydroxylation. III. Effect of ascorbic acid on hydroxylation of acetanilide, aniline and antipyrinein vivo, J. Pharmacol. Exp. Ther. 111:176–181.Google Scholar
  11. Balazs, T., J. B. Murphy, and H. C. Grice. 1962. The influence of environmental changes on the car-diotoxicity of isoprenoline in rats.J. Pharm. Pharmacol. 14:750–755.Google Scholar
  12. Bartek, M. J., J. A. Labudde, and H. I. Maibach. 1972. Skin permeabilityin vivo:Comparison in rat, rabbit, pig and man.J. Invest. Dermatol.58:114–128.Google Scholar
  13. Benedict, W. F., N. Considine, and D. W. Nebert. 1973. Genetic differences in arylhydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse.Mol. Phar macol. 9:266–277.Google Scholar
  14. Benke, G. M., and S. D. Murphy. 1975. The influence of age on the toxicity of methyl parathion and parathion in male and female rats.Toxicol. Appl. Pharmacol. 31:254–269.Google Scholar
  15. Birnbaum, L. S., G. M. Decad, H. B. Matthews, and E. E. McConnell. 1981. Fate of 2,3,7,8-tetrach-lorodibenzofuran in the monkey.Toxicol. Appl. Pharmacol. 57:189–196.Google Scholar
  16. Boyd, E. M. 1972.Protein Deficiency and Pesticide Toxicity. Thomas, Springfield, Illinois. 468 pp.Google Scholar
  17. Brain, P., and D. Benton. 1975. The interpretation of physiological correlates of differential housing in laboratory rats.Life Sci. 24:99–116.Google Scholar
  18. Bremner, I., and J. K. Campbell. 1980. The influence of copper intake on the toxicity of cadmium.Ann. N.Y. Acad. Sci. 355:319–332.Google Scholar
  19. Burg, A. W. 1975. Physiological disposition of caffeine.Drug Metab. Rev. 4:199–228.Google Scholar
  20. Cagen, S. Z., and C. D. Klaassen. 1979. Hepatotoxicity of carbon tetrachloride in developing rats.Toxicol. Appl. Pharmacol. 50:347–354.Google Scholar
  21. Calabrese, E. J., G. Moore, and R. Brown. 1979. Effects of environmental oxidant stressors on individuals with a G-6-PD deficiency with particular reference to an animal model.Environ. Health Perspect. 29:49–55.Google Scholar
  22. Capel, I. D., M. Jenner, M. H. Pinnock, H. M. Dorrell, and D. C. Williams. 1980a. The effect of isolation stress on some hepatic drug and carcinogen metabolizing enzymes in rats. J.Environ. Pathol. Toxicol. 4:337–344.Google Scholar
  23. Capel, I. D., M. Jenner, M. H. Pinnock, H. M. Dorrell, and D. C. Williams. 1980b. The effect of overcrowding stress on carcinogen-metabolizing enzymes of the rat.Environ. Res. 23:162–169.Google Scholar
  24. Chance, M. R. A. 1946. Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice.J. Pharmacol. Exp. Ther. 87:214–219.Google Scholar
  25. Clemens, T. L., R. N. Hill, L. P. Bullock, W. D. Johnson, L. G. Sultatos, and E. S. Vesell. 1979. Chloroform toxicity in the mouse: Role of genetic factors and steroids.Toxicol. Appl. Pharmacol. 48:117–130.Google Scholar
  26. Collins, T. F. X., J. J. Welsh, T. N. Black, and D. I. Ruggles. 1983. A study of the teratogenic potential of caffeine ingested in drinking water.Food Chem. Toxicol. 24:763–777.Google Scholar
  27. Dematteis, F., B. E. Prior, and C. Rimington. 1961. Nervous and biochemical disturbances following hexachlorobenzene intoxication.Nature191:363–366.Google Scholar
  28. Dixon, R. L., L. G. Hart, and J. R. Fouts. 1961. The metabolism of drugs by liver microsomes from alloxan-diabetic rats.J. Pharamacol. Exp. Ther. 133:7–11.Google Scholar
  29. Dring, L. G., R. L. Smith, and R. T. Williams. 1970. The metabolic fate of amphetamine in man and other species.Biochem. J. 116:425–435.Google Scholar
  30. Dubois, K. P., J. Doull, P. R. Salerno, and J. M. Coon. 1949. Studies on the toxicity and mechanism of action of p-nitrophenyl diethyl thionophosphate (parathion). J.Pharmacol. Exp. Ther. 95:79– 91.Google Scholar
  31. Ehrlich, R. 1980. Interaction between environmental pollutants and respiratory infections.Environ. Health Perspect. 35:89–100.Google Scholar
  32. Facchini, V., and L. A. Griffiths. 1981. The involvement of the gastro-intestinal microflora in nitro-compound-induced methaemoglobinaemia in rats and its relationship to nitro-group reduction.Biochem. Pharmacol. 30:931–935.Google Scholar
  33. Fancher, O. E. 1978. Species selection and animal models for toxicological study.Clin. Toxicol. 12:239–247.Google Scholar
  34. Forrest, J. A. H., N. D. C. Finlayson, K. K. Dejepon Yamoah, and L. F. Prescott. 1975. Antipyrine, lignocaine and paracetamol metabolism in chronic liver disease.Gut16:828–829.Google Scholar
  35. Fox, M. R. S., R. M. Jacobs, A. O. L. Jones, G. E. Fry, and C. L. Stone. 1980. Effect of vitamin C and iron on cadmium metabolism.Ann. N.Y. Acad. Sci. 355:249–261.Google Scholar
  36. Gagne, J., and J. Brodeur. 1972. Metabolic studies on the mechanisms of increased susceptibility of weanling rats to parathion.Can. J. Physiol. Pharmacol. 50:902–915.Google Scholar
  37. Gardner, D. E. 1980. Influence of exposure patterns of nitrogen dioxide on susceptibility to infectious respiratory disease. Pp. 267–288 in S. D. Lee, ed.Nitrogen Oxides and Their Effects on Health. Ann Arbor Science Publishers, Ann Arbor.Google Scholar
  38. Graham, S. L., A. Arnold, L. Kasza, G. E. Ruffin, R. C. Jackson, T. L. Watkins, and C. H. Graham. 1981. Subchronic effects of guar gum in rats.Food Cosmet. Toxicol. 19:287–290.Google Scholar
  39. Greenman, D. L., R. R. Delongchamp, and B. Highman. 1979. Variability of response to diethylstil-besterol: A comparison of inbred with hybrid mice.J. Toxicol. Environ. Health. 5:131–143.Google Scholar
  40. Hadley, W. M., T. S. Miya, and W. F. Bousquet. 1974. Cadmium inhibition of hepatic drug metabolism in the rat.Toxicol. Appl. Pharmacol. 28:284–291.Google Scholar
  41. Held, H., and M. Przerwa. 1976. Effect of the female sexual cycle on the activity of δ-aminolevulinate synthetase in rat liver.Eur. J. Clin. Invest. 6:411–413.Google Scholar
  42. Hepner, G. W., E. S. Vesell, A. Lipton, H. A. Harvey, G. R. Wilkinson, and S. Schenker. 1977. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant therapy: Diazepam breath test and correlations in drug elimination. J.Lab. Clin. Med. 90:440–456.Google Scholar
  43. Higuchi, T., T. Nakamura, and H. Uchino. 1980. Antipyrine metabolism in cancer patients.Exper-ientia36:236–238.Google Scholar
  44. Hill, R. N., T. L. Clemens, D. K. Liu, E. S. Vesell, and W. D. Johnson. 1975. Genetic control of chloroform toxicity in mice.Science190:159–161.Google Scholar
  45. Hoyumpa, A. M., R. A. Branch, and S. Schenker. 1978. The disposition and effects of sedatives and analgesics in liver disease.Annu. Rev. Med. 29:205–218.Google Scholar
  46. Jaeger, R. J., R. B. Conolly, and S. D. Murphy. 1973. Diurnal variation of hepatic glutathione concentration and its correlation with 1,1-dichloroethylene inhalation toxicity in rats.Res. Commun. Chem. Pathol. Pharmacol. 6:465–471.Google Scholar
  47. Jaeger, R. J., R. B. Conolly, and S. D. Murphy. 1974. Effect of 18 hr fast on 1,1-dichloroethylene-induced hepatotoxicity and lethality in rats.Exp. Mol. Pathol. 20:187–198.Google Scholar
  48. Kappas, A., K. E. Anderson, A. H. Conney, and A. P. Alvares. 1976. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.Clin. Pharamacol. Ther. 20:643–653.Google Scholar
  49. Kato, R. 1974. Sex-related differences in drug metabolism.Drug Metab. Rev. 3:1–32.Google Scholar
  50. Kato, R. 1977. Drug metabolism under pathological and abnormal physiological states in animals and man.Xenobiotica1/2:25–92.Google Scholar
  51. Kato, R., A. Takanaka, and A. Takahashi. 1970. Decrease in the substrate interaction with cytochrome P-450 in drug hydroxylation by liver microsomes from rats bearing Walker 256 carcinosarcoma.Gann61:359–365.Google Scholar
  52. Kellermann, G., M. Luyten-Kellermann, M. G. Horning, and M. Stafford. 1976. Elimination of antipyrine and benzo(a)pyrene metabolism in cultured human lymphocytes.Clin. Pharmacol. Ther. 20:72–80.Google Scholar
  53. Kimura, E. T., D. M. Ebert, and P. W. Dodge. 1971. Acute toxicity and limits of solvent residues for 16 organic solvents.Toxicol. Appl. Pharmacol. 19:699–704.Google Scholar
  54. Koch, R. L., B. B. Beaulieu, and P. Goodman. 1980. Role of intestinal flora in the metabolism of misonidazole.Biochem. Pharmacol. 29:3281–3284.Google Scholar
  55. Levine, R. R. 1983.Pharmacology: Drug Actions and Reactions,3d ed. Little, Brown and Co., Boston.Google Scholar
  56. Levy, A. J., S. Sherlock, and D. Walker. 1968. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.Lancet1:1275–1279.Google Scholar
  57. Lindsey, J. R., M. W. Conner, and J. J. Baker. 1978. Physical, chemical and microbial factors affecting biologic response. Pp. 31–43 inLaboratory Animal Housing. National Academy of Sciences, Washington, D.C.Google Scholar
  58. MacLeod, S. M., K. W. Renton, and N. R, Eade. 1972. Development of hepatic microsomal drug-oxidizing enzymes in immature male and female rats. J.Pharamacol. Exp. Ther. 183:489–498.Google Scholar
  59. Mainigi, K. D., and T. C. Campbell. 1981. Effect of sex differences on subcellular distribution of afla-toxin in F-344 rats treated with various risk-modifying factors.Toxicol. Appl. Pharmacol. 58:236– 243.Google Scholar
  60. Mawer, G. E., N. E. Miller, and L. A. Turnberg. 1972. Metabolism of amylobarbitone in patients with chronic liver disease.Br. J. Pharmacol. 44:549–560.Google Scholar
  61. McConnell, E. E., and J. A. Moore. 1975. Toxicopathology characteristics of the halogenated aromat-ics.Ann. N.Y. Acad. Sci. 320:138–150.Google Scholar
  62. McKenna, M. J., J. A. Zempel, E. O. Madrid, and P. J. Gehring. 1978. The pharmacokinetics of (l4C) vinylidene chloride exposure in rats following inhalation exposure.Toxicol. Appl. Pharmacol. 45:599–610.Google Scholar
  63. McMartin, K. E., G. Martin-Amat, A. B. Mekar, and T. R. Tephly. 1977. Methanol poisoning. V. Role of formate metabolism in the monkey.J. Pharmacol. Exp. Ther. 201:546–572.Google Scholar
  64. McMartin, K. E., G. Martin-Amat, P. E. Noker, and T. R. Tephly. 1979. Lack of a role for formaldehyde in methanol poisoning in the monkey.Biochem. Pharmacol. 28:645–649.Google Scholar
  65. Mirkin, B. L. 1978. Pharmacodynamics and drug disposition in pregnant women, in neonates and in children. Pp. 127–152 in K. L. Melmon and H. F. Morreli, eds.Clinical Pharmacology. Macmil-lan, New York.Google Scholar
  66. Mitzutani, T., and T. Mitsuoka. 1979. Effect of intestinal bacteria on incidence of liver tumors in gnotobiotic C3H/He male mice.J. Natl. Cancer Inst. 63:1365–1369.Google Scholar
  67. Mulvihill, J. J. 1973. Caffeine as teratogen and mutagen.Teratology8:69–72.Google Scholar
  68. Nabeshima, T., and I. K. Ho. 1981. Pharmacological responses to pentobarbital in different strains of mice.J. Pharmacol. Exp. Ther. 216:198–204.Google Scholar
  69. Nair, V., and R. Casper. 1969. The influence of light on daily rhythm in hepatic drug metabolizing enzymes in rat.Life Sci. 8:1291–1298.Google Scholar
  70. Neal, R. A., and K. P. Dubois. 1965. Studies on the mechanism of detoxification of cholinergic phos-phorothioates.J. Pharmacol. Exp. Ther. 148:185–192.Google Scholar
  71. Nebert, D. W., W. F. Benedict, J. E. Gielen, F. Oesch, and J. W. Daly. 1972. Aryl hydrocarbon hydroxylase, epoxide hydrase and 7,12-dimethylbenz(a)anthracene-produced skin tumorigenesis in the mouse.Mol. Pharmacol. 8:374–379.Google Scholar
  72. Needham, W. P., L. Shuster, G. C. Kanel, and M. L. Thompson. 1981. Liver damage from narcotics in mice.Toxicol. Appl. Pharmacol. 58:157–170.Google Scholar
  73. Nelson, E. 1964. Rate of metabolism of tolbutamide in test subjects with liver disease or with impaired renal function.Am. J. Med. Sci. 248:657–659.Google Scholar
  74. Newberne, P. M., and W. H. Butler. 1969. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review.Cancer Res. 29:236–250.Google Scholar
  75. Newberne, P. M., and G. N. Wogan. 1968. Sequential morphological changes in aflatoxin B1 carcinogenesis in the rat.Cancer Res. 28:770–781.Google Scholar
  76. Newton, W. M. 1978. Environmental impact on laboratory animals.Adv. Vet. Sci. Comp. Med. 22:1– 28.Google Scholar
  77. Nitzan, M., B. Volovitz, and E. Topper. 1979. Infantile methemoglobinemia caused by food additives.Clin. Toxicol. 15:273–280.Google Scholar
  78. Nomiyama, K., and H. Nomiyama. 1971. Metabolism of trichloroethylene in human.Int. Arch. Arbeitsmed. 28:37–48.Google Scholar
  79. Ockner, R. K., and R. Schmid. 1961. Acquired porphyria in man and rat due to hexachlorobenzene intoxication.Nature189:499.Google Scholar
  80. Pacifici, G. M., A. R. Doobis, M. J. Brodie, M. E. McManus, and D. S. Davies. 1981. Tissue and species differences in enzymes of epoxide metabolism.Xenobiotica11:73–79.Google Scholar
  81. Pantuck, E. J., K.-C. Hsiao, A. Maggio, K. Nakamura, R. Kuntzman, and A. H. Conney. 1974. Effect of cigarette smoking on phenacetin metabolism.Clin. Pharmacol. Ther. 15:9–17.Google Scholar
  82. Pantuck, E. J., K.-C. Hsiao, A. H. Conney, W. A. Garland, A. Kappas, K. E. Anderson, and A. P. Alvares. 1976. Effect of charcoal-broiled beef on phenacetin metabolism in man.Science194:1055–1057.Google Scholar
  83. Pantuck, E. J., C. B. Pantuck, W. A. Garland, B. H. Min, L. W. Wattenberg, K. E. Anderson, A. Kappas, and A. H. Conney. 1979. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism.Clin. Pharmacol. Ther. 25:88–95.Google Scholar
  84. Prehn, L. M., and E. M. Lawler. 1979. Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogens.Science204:309–310.Google Scholar
  85. Purchase, I. F. H. 1980. Interspecies comparisons of carcinogenicity.Br. J. Cancer41:454–468.Google Scholar
  86. Radzialowski, F. M., and W. F. Bousquet. 1968. Daily rhythmic variation in hepatic drug metabolism in the rat and mouse.J. Pharmacol. Exp. Ther. 163:229–238.Google Scholar
  87. Reddy, B. G., L. R. Pohl, and G. Krishna. 1976. The requirement of gut flora in nitrobenzene-induced methemoglobinemia in rats.Biochem Pharmacol. 25:1119–1122.Google Scholar
  88. Reinke, L. A., S. J. Stohs, and H. Rosenberg. 1978. Altered activity of hepatic mixed function mono-oxygenase enzymes in streptozotocin-induced diabetic rats.Xenobiotica8:611–619.Google Scholar
  89. Renwick, A.G. ,and R. T. Williams. 1972. The metabolites of cyclohexylamine in man and certain animals.Biochem. J. 129:847–867.Google Scholar
  90. Righter, H. F., W. T. Shalkop, H. D. Mercer, and E. C. Leffel. 1972. Influence of age and sexual status on the development of toxic effects in the male rat fed aflatoxins.Toxicol. Appl. Pharmacol. 21:435–439.Google Scholar
  91. Riley, V. 1981. Psychoneuroendocrine influences on immunocompetence and neoplasia.Science212:1100–1109.Google Scholar
  92. Ringler, D. H., and L. Dabich. 1979. Hematology and clinical biochemistry. Pp. 105–121 in H. J. Baker, R. Lindsey, and S. H. Weisbroth, eds.The Laboratory Rat,Volume 1.Biology and Diseases. Academic Press, New York.Google Scholar
  93. Robinson, J. R., J. S. Felton, R. C. Levitt, S. S. Thorgeirsson, and D. W. Nebert. 1975. Relationship between “aromatic hydrocarbon responsiveness” and the survival times in mice treated with various drugs and environmental compounds.Mol. Pharmacol. 11:850–865.Google Scholar
  94. Romero, J. A. 1976. Influence of diurnal cycles on biochemical parameters of drug sensitivity: The pineal gland as a model.Fed. Proc. 35:1157–1161.Google Scholar
  95. Rose, J. Q., A. M. Yurchak, A. W. Meikle, and W. J. Jusko. 1981. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.J. Pharmacokin. Biopharm. 9:1–14.Google Scholar
  96. Ross, R. H., A. L. Sermons, J. O. Owasoyo, and C. A. Walker. 1981. Circadian variation of diazepam acute toxicity in mice.Experientia37:72.Google Scholar
  97. Rosso, R., M. G. Donelli, G. Franchi, and S. Garattini. 1971. Impairment of drug metabolism in tumor-bearing animals.Eur. J. Cancer7:565–577.Google Scholar
  98. Rubin, E., and C. S. Lieber. 1968. Hepatic microsomal enzymes in man and rat: Induction and inhibition by ethanol.Science162:690–691.Google Scholar
  99. Rubin, E., H. Gang, P. S. Misra, and C. S. Lieber. 1970. Inhibition of drug metabolism by acute ethanol intoxication.Am. J. Med. 49:801–806.Google Scholar
  100. Sabine, J. R., B. J. Horton, and M. B. Wicks. 1973. Spontaneous tumors in C3H-Avy and C3H-AvyfB mice: High incidence in the United States and low incidence in Australia.J. Natl. Cancer Inst. 50:1237–1242.Google Scholar
  101. Sakellaris, P. C., A. Peterson, A. Goodwin, C. M. Winget, and J. Vernikos-Danellis. 1975. Response of mice to repeated photoperiod shifts: Susceptibility to stress and barbiturates.Proc. Soc. Exp. Biol. Med. 149:677–680.Google Scholar
  102. San Martin de Viale, C., A. A. Viale, S. Nacht, and M. Grinstein. 1970. Experimental porphyria induced in rats by hexachlorobenzene. Study of the porphyrins excreted by urine.Clin. Chim. Acta28:13–23.Google Scholar
  103. Sansone, E. B., A. M. Losikoff, and R. A. Pendleton. 1977. Sources and dissemination of contamination in material handling operations.Am. Ind. Hyg. Assoc. J. 38:433–442.Google Scholar
  104. Sanvordeker, D. R., and H. J. Lambert, 1974. Environmental modification of mammalian drug metabolism and biological responses.Drug Metab. Rev. 3:201–229.Google Scholar
  105. Schanker, L. S. 1978. Drug absorption from the lung.Biochem. Pharmacol. 27:381–385.Google Scholar
  106. Schoene, B., R. A. Fleischmann, H. Remmer, and H. F. V. Oldershausen. 1972. Determination of drug metabolizing enzymes in needle biopsies of human liver.Eur. J. Clin. Pharmacol. 4:65–73.Google Scholar
  107. Sereni, F., M. Mandelli, N. Principi, G. Tognoni, G. Pardi, and P. L. Morselli. 1973. Induction of drug metabolizing enzyme activities in the human fetus and newborn infant.Enzyme15:318–329.Google Scholar
  108. Short, C. R., D. A. Kinden, and R. Stith. 1976. Fetal and neonatal development of the microsomal monoxygenase system.Drug Metab. Rev. 5:1–42.Google Scholar
  109. Sievers, R. F., and A. R. McIntyre. 1937. The effects of temperature upon the toxicity of procaine for white mice.J. Pharmacol. Exp. Ther. 59:90–92.Google Scholar
  110. Singlevich, T. E., and J. J. Barboriak. 1971. Ethanol induction of microsomal drug-metabolizing enzymes in the rat.Toxicol. Appl. Pharmacol. 20:284–290.Google Scholar
  111. Sotaniemi, E. A., J. Ahlqvist, R. O. Pelkonen, H. Pirttiaho, and P. V. Luoma. 1977. Histological changes in the liver and indices of drug metabolism in alcoholics.Eur. J. Clin. Pharmacol. 11:295–303.Google Scholar
  112. Tannenbaum, A., and H. Silverstone. 1949. The genesis and growth of tumors. IV. Effects of varying the proportion of protein (casein) in the diet.Cancer Res. 9:162–173.Google Scholar
  113. Tschanz, C., C. E. Hignite, D. H. Huffman, and D. L. Azarnoff. 1977. Metabolic disposition of anti-pyrine in patients with lung cancer.Cancer Res. 37:3881–3886.Google Scholar
  114. Ueda, H., T. Sakurai, M. Ota, A. Nakajima, K. Kamii, and H. Maezawa. 1963. Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis and renal disease.Diabetes12:414–419.Google Scholar
  115. Vesell, E. S. 1967. Induction of drug-metabolizing enzymes in liver microsomes of mice and rats by softwood bedding.Science157:1057–1058.Google Scholar
  116. Vesell, E. S. 1978. Disease as one of many variables affecting drug disposition and response: Alteration of drug disposition in liver disease.Drug Metab. Rev. 8:265–291.Google Scholar
  117. Vesell E. S., C. M. Lang., W. J. White, G. T. Passananti, and S. L. Tripp. 1973. Hepatic drug metabolism in rats: Impairment in a dirty environment.Science179:896–897.Google Scholar
  118. Vesell, E. S., C. M. Lang, W. J. White, G. T. Passananti, R. N. Hill, T. L. Clemens, D. K. Liu, and W. D. Johnson. 1976. Environmental and genetic factors affecting the response of laboratory animals to drugs.Fed. Proc. 35:1125–1132.Google Scholar
  119. Vesell, E. S., C. A. Shively, and G. T. Passananti. 1977. Temporal variations of antipyrine half-life in man.Clin. Pharmacol. Ther. 22:843–852.Google Scholar
  120. Weihe, W. H. 1973. The effect of temperature on the action of drugs.Annu. Rev. Pharmacol. 13:409– 425.Google Scholar
  121. Welch, R. M., J. Cavallito, and A. Loh. 1972. Effect of exposure to cigarette smoke on the metabolism of benzo(#)pyrene and acetophenetidin by lung and intestine of rats.Toxicol. Appl. Pharmacol. 23:749–758.Google Scholar
  122. Wester, R. C, and H. I. Maibach. 1975. Percutaneous absorption in the rhesus monkey compared to man.Toxicol. Appl. Pharmacol. 32:394–398.Google Scholar
  123. Whitlock, R. H., N. A. White, G. N. Rowland, and R. Plue. 1978. Monensin toxicosis in horses: Clinical manifestations.Annu. Conv. Am. Assoc. Equine Pract. 24:473–486.Google Scholar
  124. Willes, R. F. 1977. Tissue distribution as a factor in species susceptibility to toxicity and hazard assessment. Example: methylmercury.J. Environ. Pathol. Toxicol. 1:135–146.Google Scholar
  125. Williams, R. T. 1974. Inter-species variations in the metabolism of xenobiotics.Biochem. Soc. Trans. 2:359–377.Google Scholar
  126. Willson, R. A., and F. E. Hart. 1977. Effect of experimental hepatic injury onin vitrodrug metabolizing enzyme activities in the rat.Gastroenterology73:691–696.Google Scholar
  127. Wood, A. J. J., R. E. Vestal, G. R. Wilkinson ,R. A. Branch, and D. G. Shand. 1979. Effect of aging and smoking on antipyrine and indocyanine green elimination.Clin. Pharmacol. Ther. 26:16–20.Google Scholar
  128. Yang, R. S. H., F. Coulston, and L. Goldberg. 1975. Binding of hexachlorobenzene to erythrocytes: Species variation.Life Sci. 17:545–550.Google Scholar
  129. Yeary, R. A. 1967. Drug toxicity in newborn animals.Appl. Ther. 9:918–921.Google Scholar
  130. Zannoni, V. G., E. J. Flynn, and M. Lynch. 1972. Ascorbic acid and drug metabolism.Biochem. Phar macol. 21:1377–1392.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Gary P. Carlson
    • 1
  1. 1.Department of Pharmacology and Toxicology, School of Pharmacy and Pharmacal SciencePurdue UniversityWest LafayetteUSA

Personalised recommendations